Biocon's Q2 adj. PAT rises 3% yoy on higher R&D & employee costs

Net Profit on a yoy basis was lower at Rs216cr (vs. Rs355cr in Q2FY19) due to an exceptional income of Rs171cr reported in Q2FY19.

from India Infoline News Service https://ift.tt/2qFCDCY